Stifel Nicolaus Sticks to Its Buy Rating for Bicara Therapeutics Inc. (BCAX)
Stifel Nicolaus analyst Stephen Willey maintained a Buy rating on Bicara Therapeutics Inc. (BCAX – Research Report) today. The company’s shares ...
Stifel Nicolaus Sticks to Their Buy Rating for Generac Holdings (GNRC)
Stifel Nicolaus analyst Stephen Gengaro maintained a Buy rating on Generac Holdings (GNRC – Research Report) today and set a price target of ...
Stifel raises Insmed stock target to $97, maintains Buy rating
Stifel analysts maintained their Buy rating on Insmed shares (NASDAQ:INSM) and increased the price target from $88.00 to $97.00. According to InvestingPro data, the stock has delivered an impressive ...
MarketWatch21h
Portillo's Inc.
Papa John's International Inc. 2.79% $1.24B ...